DK0782630T3 - Polycystisk nyresygdomsgen - Google Patents

Polycystisk nyresygdomsgen

Info

Publication number
DK0782630T3
DK0782630T3 DK95938775T DK95938775T DK0782630T3 DK 0782630 T3 DK0782630 T3 DK 0782630T3 DK 95938775 T DK95938775 T DK 95938775T DK 95938775 T DK95938775 T DK 95938775T DK 0782630 T3 DK0782630 T3 DK 0782630T3
Authority
DK
Denmark
Prior art keywords
pkd1
kidney disease
polycystic kidney
gene
disease gene
Prior art date
Application number
DK95938775T
Other languages
English (en)
Inventor
Katherine W Klinger
Gregory M Landes
Timothy C Burn
Timothy D Connors
William Dackowski
Gregory Germino
Feng Qian
Original Assignee
Genzyme Corp
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/323,443 external-priority patent/US5654170A/en
Application filed by Genzyme Corp, Univ Johns Hopkins filed Critical Genzyme Corp
Application granted granted Critical
Publication of DK0782630T3 publication Critical patent/DK0782630T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95938775T 1994-10-12 1995-10-11 Polycystisk nyresygdomsgen DK0782630T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/323,443 US5654170A (en) 1994-10-12 1994-10-12 Polycystic kidney disease gene
US38152095A 1995-01-31 1995-01-31

Publications (1)

Publication Number Publication Date
DK0782630T3 true DK0782630T3 (da) 2006-05-29

Family

ID=26983965

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95938775T DK0782630T3 (da) 1994-10-12 1995-10-11 Polycystisk nyresygdomsgen

Country Status (10)

Country Link
US (1) US6867288B1 (da)
EP (1) EP0782630B1 (da)
AT (1) ATE316136T1 (da)
AU (1) AU706167B2 (da)
CA (1) CA2202283A1 (da)
DE (1) DE69534753T2 (da)
DK (1) DK0782630T3 (da)
ES (1) ES2256851T3 (da)
PT (1) PT782630E (da)
WO (1) WO1996012033A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599719B2 (en) * 1994-11-07 2003-07-29 Human Genome Sciences, Inc. Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha
US6824767B2 (en) * 1994-11-07 2004-11-30 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
JP2002503952A (ja) * 1996-05-24 2002-02-05 ジェンザイム・コーポレーション 多嚢胞性腎疾患遺伝子
DE19650758C1 (de) * 1996-12-06 1998-01-02 Deutsches Krebsforsch PKD1-Fragmente mit Bindungsregionen für PKD1-spezifische Antikörper
AU9303498A (en) * 1997-09-02 1999-03-22 Medical College Of Georgia Research Institute, Inc. Human aminopeptidase p gene
AU2001271998A1 (en) 2000-07-13 2002-01-30 The Johns Hopkins University School Of Medicine Detection and treatment of polycystic kidney disease
JP2009544314A (ja) 2006-07-24 2009-12-17 アテナ ダイアグノスティックス，インコーポレイテッド Ｐｋｄの変異およびその評価
US8424594B2 (en) * 2007-12-10 2013-04-23 Presto Engineering, Inc. Apparatus for thermal control in the analysis of electronic devices
US20140037549A1 (en) * 2011-02-16 2014-02-06 Compugen Ltd. Genetic markers for prognosis of rheumatoid arthritis treatment efficacy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232452B1 (en) * 1993-12-24 2001-05-15 Julian R. Sampson Tuberous sclerosis 2 gene and uses thereof
EP0777728A1 (en) * 1994-06-14 1997-06-11 Medical Research Council Polycystic kidney disease 1 gene and uses thereof
US6071717A (en) * 1995-01-31 2000-06-06 Genzyme Corporation Polycystic kidney disease gene and protein

Also Published As

Publication number Publication date
EP0782630A4 (en) 1997-12-17
ES2256851T3 (es) 2006-07-16
EP0782630B1 (en) 2006-01-18
AU4002795A (en) 1996-05-06
DE69534753D1 (de) 2006-04-06
JP4495255B2 (ja) 2010-06-30
CA2202283A1 (en) 1996-04-25
JP2001520502A (ja) 2001-10-30
DE69534753T2 (de) 2006-11-02
ATE316136T1 (de) 2006-02-15
PT782630E (pt) 2006-06-30
US6867288B1 (en) 2005-03-15
AU706167B2 (en) 1999-06-10
WO1996012033A1 (en) 1996-04-25
EP0782630A1 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
WO1998026747A3 (en) Superantigen based methods and compositions for treatment of diseases
ZA200200789B (en) Multiple cytokine-antibody complexes.
AUPN568095A0 (en) Anti-Galalpha(1,3)Gal antibody binding peptides
CA2157927A1 (en) Therapeutic uses of bactericidal/permeability increasing protein produc ts
DE69410254T2 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
AU1679795A (en) Anti-fungal methods and materials
DK0782630T3 (da) Polycystisk nyresygdomsgen
ATE527358T1 (de) Ribosomen inaktivierendes protein vom typ-1
DE69731463D1 (de) Rekombinante ribonuklease proteine
EP0716591A4 (en) METHODS AND COMPOSITIONS FOR FIXING TAU AND MAP2c PROTEINS
NO963487L (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
FI961584A0 (fi) C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
AUPM772494A0 (en) Improvements in production of proteins in host cells
DK0938329T3 (da) Immunogen TLP sammensætning
DE58907373D1 (de) Modifizierte Proteine.
NZ334762A (en) Human DNase I variants having binding affinity to actin
IT1276765B1 (it) Gene del cromosoma x umano e proteina codificata da detto gene.